Bipolar Disorder Clinical Trials

Showing 301-320 of 704 trials

A Non-Interventional Post-Marketing Surveillance Study to Evaluate the Safety and Efficacy of Zeldox Capsule

NCT01053429

This is a regulatory-required non-interventional pharmacovigilance study exploring the safety profile of ziprasidone HCL monohydrate 20mg, 40mg, 60mg, 80mg in the real world patient population, thus, safety (and/or efficacy) signals will be checked at every visit during the contracted study period until the maximum study end date, per the protocol, of April 2010.

Bipolar DisorderSchizophrenia

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.3,391 participantsStarted Jun 2005

COMPLETED

BIMET Study: Evolution of Metabolic and Cardiovascular Risks Factors in Patients With Bipolar Disorder

NCT00584961

To assess the prevalence of Metabolic Syndrome in Spanish population with Bipolar I or II Disorder. To analyse the clinical progress disease in patients with Bipolar I or II Disorder for 12 months using the assessment of the symptoms disease and the progress of metabolic and cardiovascular risk. To analyse the health status, quality of life and functioning/disability of patients.

Bipolar Disorder

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.553 participantsStarted May 2007

COMPLETEDPhase 2

A Study of the Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic Disorders

NCT00650611

The purpose of this study is to evaluate the safety and tolerability of oral ziprasidone in children and teens with psychotic disorders

SchizophreniaBipolar DisorderSchizoaffective Disorder

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.63 participantsStarted Dec 2003

San Diego, California, United States • Altamonte Springs, Florida, United States • Libertyville, Illinois, United States +14 more locations

A Non-Interventional Post-Marketing Surveillance Study to Evaluate the Safety and Efficacy of Zeldox Capsule

BIMET Study: Evolution of Metabolic and Cardiovascular Risks Factors in Patients With Bipolar Disorder

A Study of the Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic Disorders

Related Searches

Safety And Efficacy Of Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed) (Protocol A1281196)

Brief Motivational Intervention to Improve Medication Adherence for Adolescents With Bipolar Disorder

Identification of Predictive Biomarkers of Mood Relapses in Patients With Bipolar Disorder

Treating Insulin Resistance as a Strategy to Improve Outcome in Refractory Bipolar Disorder

Study to Promote Innovation in Rural Integrated Telepsychiatry

Management of my Bipolarity Intervention in Bipolar Disorder Patients

Cost- Effectiveness and Quality of Life Assessment in Mood Disorder

Gabapentin for Bipolar & Cannabis Use Disorders

Rostral Dorsal Cingulum Bundle Connectivity in Patients With Bipolar Disorder

Effectiveness of a Mobile Texting Intervention for People With Serious Mental Illness

Placebo Controlled Trial of Valproate and Risperidone in Young Children With Bipolar Disorders

Study of Maca Root to Treat Sexual Dysfunction Associated With the Treatment Regimen for Bipolar Disorder in Females

Functionality and Neurocognition in Patients With Bipolar Disorder After a Physical-exercise Program (FINEXT-BD Study)

Reward and Punishment Sensitivity in Bipolar Disorders

Study Comparing Magnetic Seizure Therapy (MST) to Electroconvulsive Therapy (ECT) for Depression in Older Adults

Brain Stimulation and Cognitive Training

Sequential Multiple Assignment Treatment for Bipolar Disorder